CaMPR-BASIC (Collaborative and Multidisciplinary Pilot Research Award for Basic Science and Clinical/Translational Investigators)
The Irving Institute's CaMPR program was created to: (1) support multidisciplinary research; (2) train and mentor a new generation of multidisciplinary research teams; and (3) expand and optimize the utilization of CUMC’s outstanding research resources. Up until now, CaMPR investigators have been almost exclusively based in clinical departments.
CaMPR-BASIC takes the next step towards the development of multidisciplinary teams by offering support for collaborations between researchers from basic science departments from either the CUMC or Morningside campus and clinical/translational investigators on the medical campus.
Applicants to CaMPR-BASIC are required to form a NEW collaborative team consisting of two Principal Investigators at the Assistant Professor level: one from a basic science department, and one from a clinical department.
The Basic Science PI must hold an Assistant Professor appointment at the Columbia College of Physicians and Surgeons in one of the following departments: Biochemistry and Molecular Biophysics, Biomedical Informatics, Microbiology and Immunology, Pathology and Cell Biology, Pharmacology, Physiology and Cellular Biophysics, Genetics and Development, and Neuroscience. Assistant Professors in departments at the Morningside Campus, such as the Department of Biomedical Engineering, the Department of Chemistry, or the Department of Biology, are also eligible.
The Basic Science PI may choose a clinical investigator from any of the four CUMC schools for the role of the Clinical PI. The new collaborative team may not have produced any publications together nor shared research funding in the past.
Research focus should be on PILOT STUDIES that will lead to independent, external funding. These awards are not intended to supplement or overlap with on-going funded research, nor are they meant to support research teams already in existence. The project will be focused at the pre-clinical level, with relevance to a clinical problem. The goal of the program is to bring clinical focus and experience to the pre-clinical research, i.e., to ensure that the cell or animal model is appropriate; that the target molecule is specific; and that the pre-clinical approach has potential for significant translation to humans.
Guidelines for Application
CaMPR-BASIC involves a two-phase / two-step application process:
Phase I – Letter of Intent
Phase I consists of a Letter of Intent due. All submitted Phase I Letters of Intent will be reviewed, then the teams selected to move forward in the application process will be notified and required to submit a Full Application. Only the teams that are selected to apply for the Phase II Full Application will be eligible to compete for up to two $40,000 pilot awards.
Phase II – Full Application Pilot Award
Duration: 1 year
Award Amount: $40,000
Quantity: Up to two (2)
See our poster on the CaMPR-BASIC pilot program, presented at the annual Translational Science meeting in Washington, DC on April 9-11, 2014.
|Have a question? Submit Consultation Request||top|